Online Database of Chemicals from Around the World
| Taizhou Crene Biotechnology Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
 |
+86 (576) 8881-3233 8820-5808 +86 13396860566 | |||
 |
order@pharm-intermediates.com | |||
 |
QQ chat | |||
| Chemical manufacturer since 2011 | ||||
| chemBlink standard supplier since 2009 | ||||
| BOC Sciences | USA | Inquire | ||
|---|---|---|---|---|
|
+1 (631) 485-4226 | |||
|
info@bocsci.com | |||
| Chemical manufacturer | ||||
| chemBlink standard supplier since 2010 | ||||
| Molcan Corporation | USA | Inquire | ||
|---|---|---|---|---|
|
+1 (905) 731-5537 | |||
|
info@molcan.com | |||
| Chemical manufacturer | ||||
| chemBlink standard supplier since 2012 | ||||
| Leap Chem Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
|
+86 (852) 3060-6658 | |||
|
market19@leapchem.com | |||
|
QQ chat | |||
| Chemical manufacturer since 2006 | ||||
| chemBlink standard supplier since 2015 | ||||
| Look Pharma Limited | China | Inquire | ||
|---|---|---|---|---|
|
+86 18188632805 | |||
|
lookpharma@outlook.com | |||
| Chemical manufacturer since 2017 | ||||
| chemBlink standard supplier since 2017 | ||||
| Shanghai Forever Synthesis Co.,Ltd. | China | Inquire | ||
|---|---|---|---|---|
|
+86 (551) 6288-8437 +86 18096409024 | |||
|
sales@foreversyn.com sales02@foreversyn.com | |||
 |
Skype Chat | |||
|
QQ chat | |||
| Chemical distributor since 2013 | ||||
| chemBlink standard supplier since 2018 | ||||
| Santa Cruz Biotechnology, Inc. | USA | Inquire | ||
|---|---|---|---|---|
|
+1 (831) 457-3800 | |||
|
scbt@scbt.com | |||
| Chemical manufacturer | ||||
| Classification | Biochemical >> Inhibitor >> PI3K/Akt/mTOR inhibitor (PI3K/Akt/mTOR) >> mTOR inhibitor |
|---|---|
| Name | Zotarolimus |
| Synonyms | A 179578; ABT 578; Resolute; 42-(1-Tetrazolyl)rapamycin; (42S)-42-Deoxy-42-(1H-tetrazol-1-yl)rapamycin |
| Molecular Structure |  |
| Molecular Formula | C52H79N5O12 |
| Molecular Weight | 966.21 |
| CAS Registry Number | 221877-54-9 |
| Density | 1.25 |
|---|---|
| SDS | Available |
|---|---|
| Market Analysis Reports |
| List of Reports Available for Zotarolimus |